News
23h
Fintel on MSNBTIG Upgrades Synchrony Financial - Preferred Stock (SYF.PRA)Fintel reports that on July 14, 2025, BTIG upgraded their outlook for Synchrony Financial - Preferred Stock (NYSE:SYF.PRA) ...
15h
Fintel on MSNBTIG Upgrades Synchrony Financial - Preferred Stock (SYF.PRB)Fintel reports that on July 14, 2025, BTIG upgraded their outlook for Synchrony Financial - Preferred Stock (NYSE:SYF.PRB) from Neutral to Buy. What is the Fund Sentiment? There are 39 funds or ...
Tvardi Therapeutics, Inc. ("Tvardi") (NASDAQ: TVRD), a clinical-stage biopharmaceutical company focused on the development of novel, oral, small molecule therapies targeting STAT3 to treat ...
MicroStrategy stock inches up following SEC filings that confirmed the company loaded up on more than 4,000 bitcoins. Crypto ...
Carlsmed, a spine surgery solution company, announced today that it launched its initial public offering with the start of an ...
Ultimately, the S&P 500 SPX wavered, closing lower, after flipping between gains and losses in the final hour of trade. Only 80 of the index's 503 constituents in early morning trade were in positive ...
Authorities at Tehran's Evin Prison were still attending to the dead and wounded on the evening of June 23 when one of the highest-profile inmates held there, Swedish-Iranian scientist Ahmadreza ...
GrabAGun, an online firearms retailer, completed its business combination with Colombier Acquisition Corp. II (CLBR) and is set to begin trading on the New York Stock Exchange under the ticker symbols ...
New York Mortgage Trust, Inc. (Nasdaq: NYMT) (the 'Company”) today announced that it has acquired the remaining 50% ownership interest in Constructive Loans, LLC ('Constructive”), a leading originator ...
McGraw Hill aims for a $4.2 billion valuation in its IPO, planning to raise $537 million to repay debt and expand its ...
The Centers for Medicare & Medicaid Services (CMS) has proposed eliminating product-specific reimbursement for skin substitutes. Instead, these products would be treated as "incident-to supplies," a ...
Throughout the last three months, 4 analysts have evaluated Globus Medical GMED -2.61% Get Free Report , offering a diverse set of opinions from bullish to bearish. The following table summarizes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results